FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309411838> ?p ?o ?g. }

• W4309411838 endingPage "7011" @default.
• W4309411838 startingPage "7002" @default.
• W4309411838 abstract "To analyze the changes of carbohydrate antigen 153 (CA15-3), S-100 calcium-binding protein B (S100B) and insulin-like growth factor-1 (IGF-1) in the treatment of patients with high-grade glioma and their predictive value for efficacy.In this retrospective the PG and CG study, 74 patients with glioma who were treated in the Affiliated Hospital of Yan'an University from January 2015 to January 2017 were labeled as the patient group (PG); the other 70 patients who underwent craniocerebral trauma surgery during the same period were selected as the control group (CG). The expressions of CA15-3, S100B and IGF-1 in the PG and CG were compared. The relationship between CA15-3, S100B, IGF-1, and the pathologic data of patients was analyzed. The expression differences of CA15-3, S100B, and IGF-1 were compared between low-grade glioma patients and high-grade glioma patients and their diagnostic value was analyzed. The values of CA15-3, S100B, and IGF-1 expression for predicting treatment efficacy were analyzed.Expressions of CA15-3, S100B, and IGF-1 in glioma patients were markedly higher than those in the CG (P<0.0001). The proportion of grade III+IV patients with high expression of CA15-3, S100B, and IGF-1 was higher than in grade II patients (P<0.05), and the expressions of CA15-3, S100B and IGF-1 in low-grade glioma patients were lower than in high-grade glioma (P<0.01). The AUCs of CA15-3, S100B, and IGF-1 in differentiating different grades of glioma were 0.822, 0.722, and 0.768, respectively. Serum CA15-3, S100B and IGF-1 levels of the patients after treatment were significantly lower than those before treatment (P<0.0001). With the deterioration of clinical efficacy, serum levels of CA15-3, S100B, and IGF-1 gradually increased (P<0.05), and CA15-3, S100B and IGF-1 were positively correlated with therapeutic efficacy (P<0.05). AUCs of CA15-3, S100B, and IGF-1 for predicting the clinical efficacy in glioma patients were 0.824, 0.741, and 0.800, respectively.CA15-3, S100B, and IGF-1 are highly expressed in patients with glioma. They are diagnostic indicators to distinguish patients with high-grade glioma, and have predictive value for treatment efficacy." @default.
• W4309411838 created "2022-11-27" @default.
• W4309411838 creator A5008413368 @default.
• W4309411838 creator A5012052216 @default.
• W4309411838 creator A5018863416 @default.
• W4309411838 creator A5024232094 @default.
• W4309411838 creator A5030097283 @default.
• W4309411838 creator A5043839950 @default.
• W4309411838 date "2022-01-01" @default.
• W4309411838 modified "2023-10-16" @default.
• W4309411838 title "Changes in CA15-3, S100B, and IGF-1 in glioma and their predictive value for treatment efficacy." @default.
• W4309411838 cites W1523039692 @default.
• W4309411838 cites W2083701220 @default.
• W4309411838 cites W2322348021 @default.
• W4309411838 cites W2341890933 @default.
• W4309411838 cites W2461674785 @default.
• W4309411838 cites W2528064861 @default.
• W4309411838 cites W2596796081 @default.
• W4309411838 cites W2605166836 @default.
• W4309411838 cites W2896271843 @default.
• W4309411838 cites W2901716735 @default.
• W4309411838 cites W2912947115 @default.
• W4309411838 cites W2922435357 @default.
• W4309411838 cites W2960319424 @default.
• W4309411838 cites W2992722859 @default.
• W4309411838 cites W2992728581 @default.
• W4309411838 cites W3001791812 @default.
• W4309411838 cites W3007516410 @default.
• W4309411838 cites W3015354770 @default.
• W4309411838 cites W3042636067 @default.
• W4309411838 cites W3047047172 @default.
• W4309411838 cites W3095687505 @default.
• W4309411838 cites W3128711569 @default.
• W4309411838 cites W3138484448 @default.
• W4309411838 cites W3161829336 @default.
• W4309411838 cites W3172851122 @default.
• W4309411838 cites W3174253267 @default.
• W4309411838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36398210" @default.
• W4309411838 hasPublicationYear "2022" @default.
• W4309411838 type Work @default.
• W4309411838 citedByCount "0" @default.
• W4309411838 crossrefType "journal-article" @default.
• W4309411838 hasAuthorship W4309411838A5008413368 @default.
• W4309411838 hasAuthorship W4309411838A5012052216 @default.
• W4309411838 hasAuthorship W4309411838A5018863416 @default.
• W4309411838 hasAuthorship W4309411838A5024232094 @default.
• W4309411838 hasAuthorship W4309411838A5030097283 @default.
• W4309411838 hasAuthorship W4309411838A5043839950 @default.
• W4309411838 hasConcept C126322002 @default.
• W4309411838 hasConcept C143998085 @default.
• W4309411838 hasConcept C167135981 @default.
• W4309411838 hasConcept C2778227246 @default.
• W4309411838 hasConcept C3019719930 @default.
• W4309411838 hasConcept C502942594 @default.
• W4309411838 hasConcept C71924100 @default.
• W4309411838 hasConcept C90924648 @default.
• W4309411838 hasConceptScore W4309411838C126322002 @default.
• W4309411838 hasConceptScore W4309411838C143998085 @default.
• W4309411838 hasConceptScore W4309411838C167135981 @default.
• W4309411838 hasConceptScore W4309411838C2778227246 @default.
• W4309411838 hasConceptScore W4309411838C3019719930 @default.
• W4309411838 hasConceptScore W4309411838C502942594 @default.
• W4309411838 hasConceptScore W4309411838C71924100 @default.
• W4309411838 hasConceptScore W4309411838C90924648 @default.
• W4309411838 hasIssue "10" @default.
• W4309411838 hasLocation W43094118381 @default.
• W4309411838 hasOpenAccess W4309411838 @default.
• W4309411838 hasPrimaryLocation W43094118381 @default.
• W4309411838 hasRelatedWork W2094394606 @default.
• W4309411838 hasRelatedWork W2105151527 @default.
• W4309411838 hasRelatedWork W2120419567 @default.
• W4309411838 hasRelatedWork W2324013405 @default.
• W4309411838 hasRelatedWork W2951130915 @default.
• W4309411838 hasRelatedWork W3013145321 @default.
• W4309411838 hasRelatedWork W3014841908 @default.
• W4309411838 hasRelatedWork W3198647362 @default.
• W4309411838 hasRelatedWork W3208090289 @default.
• W4309411838 hasRelatedWork W3210359220 @default.
• W4309411838 hasVolume "14" @default.
• W4309411838 isParatext "false" @default.
• W4309411838 isRetracted "false" @default.
• W4309411838 workType "article" @default.